稳定RH5病毒样粒子疫苗的临床前开发,可诱导改善的抗疟疾抗体

Lloyd D W King1, David Pulido2, Jordan R Barrett1

  • 1Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, OX1 3QU Oxford, UK; Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, University of Oxford, OX1 3QU Oxford, UK; The Jenner Institute, University of Oxford, Old Road Campus Research Building, OX3 7DQ Oxford, UK.

PubMed
概括

研究人员通过重新设计RH5蛋白质,开发了一种新的疟疾疫苗候选人RH5.2. 这种改进的版本,当与病毒样颗粒和辅助剂相结合时,与当前的疫苗方法相比,显示出优异的抗体反应.